<!DOCTYPE html>
<html lang="en">
<head>
    <base href="../">
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Brokernear | News | The Biotech Sector Is Hot, But These 3 Stocks Are Worth The Investment</title>
    <link rel="shortcut icon" href="assets/img/favicon.png">
    <link rel="stylesheet" href="assets/css/fonts.css">
    <link rel="stylesheet" href="assets/css/main.css">
    <link rel="stylesheet" href="assets/css/media.css">
</head>
<body>
    <div class="main-wrapper">

        <!-- HEADER -->
        <header class="header">
            <div class="container flex center">
                <a href="index.html" class="header-logo-link">
                    <img src="assets/img/svg/logo.svg" alt="Logo" class="header-logo" loading="lazy">
                </a>
                <div class="header-panel">
                    <div class="header-panel-upper flex center just-between">
                        <p class="header-text">
                            Read online broker reviews, view category ratings and compare brokers
                        </p>
                        <!-- <div class="header-search-bar">
                            <input type="text" placeholder="Enter broker title" class="header-search-input">
                        </div> -->
                    </div>
                    <div class="header-panel-lower flex just-between">
                        <nav class="navigation">
                            <ul class="nav-list flex center">
                                <li class="nav-list-item">
                                    <a href="reviews.html" class="nav-list-item-link">
                                        Brokers Reviews
                                    </a>
                                </li>
                                <li class="nav-list-item dropdown">
                                        Best Brokers 
                                        <img src="assets/img/svg/white-arrow-down.svg" width="12" height="7" alt="Arrow down" class="arrow-down-icon">
                                        <ul class="header-dropdown-menu">
                                            <li class="header-dropdown-menu-item">
                                                <a href="best-crypto-brokers.html" class="header-dropdown-menu-item-link">
                                                    Best crypto brokers
                                                </a>
                                            </li>
                                            <li class="header-dropdown-menu-item">
                                                <a href="best-forex-brokers.html" class="header-dropdown-menu-item-link">
                                                    Best Forex brokers
                                                </a>
                                            </li>
                                            <li class="header-dropdown-menu-item">
                                                <a href="best-stock-brokers.html" class="header-dropdown-menu-item-link">
                                                    Best stock brokers
                                                </a>
                                            </li>
                                            <li class="header-dropdown-menu-item">
                                                <a href="best-brokers-for-beginners.html" class="header-dropdown-menu-item-link">
                                                    Best brokers for beginners
                                                </a>
                                            </li>
                                            <li class="header-dropdown-menu-item">
                                                <a href="best-trading-platform.html" class="header-dropdown-menu-item-link">
                                                    Best trading platform
                                                </a>
                                            </li>
                                        </ul>
                                    </li>
                                <li class="nav-list-item">
                                    <a href="about.html" class="nav-list-item-link">
                                        About
                                    </a>
                                </li>
                                <li class="nav-list-item">
                                    <a href="contact.html" class="nav-list-item-link">
                                        Contacts
                                    </a>
                                </li>
                            </ul>
                        </nav>
                        <div class="header-auth-section flex center">
                            <!-- <a href="javascript:void(0)" class="header-auth-link log-in">
                                Log in
                            </a>
                            <a href="javascript:void(0)" class="header-auth-link sign-up">
                                Sign up
                            </a> -->
                        </div>
                    </div>
                </div>
                <div class="header-menu-btn-wrapper">
                    <img src="assets/img/svg/white-menu-burger.svg" width="24" height="16" alt="Menu" class="header-menu-btn-icon" loading="lazy" aria-label="Open Menu">
                </div>
            </div>
        </header>

        <!-- MAIN -->
        <main class="main">

            <!-- BREADCRUMBS -->
            <div class="container">
                <ul class="breadcrumbs flex center wrap">
                    <li class="breadcrumbs-item">
                        <a href="index.html" class="breadcrumbs-item-link">
                            Home
                        </a>
                    </li>
                    <img src="assets/img/svg/grey-arrow-right.svg" alt="Arrow right" class="arrow-divider-icon" loading="lazy">
                    <li class="breadcrumbs-item">
                        <a href="news.html" class="breadcrumbs-item-link">
                            News
                        </a>
                    </li>
                    <img src="assets/img/svg/grey-arrow-right.svg" alt="Arrow right" class="arrow-divider-icon" loading="lazy">
                    <li class="breadcrumbs-item">
                        <a href="javascript:void(0)" class="breadcrumbs-item-link current">
                            The Biotech Sector Is Hot, But These 3 Stocks Are Worth The Investment
                        </a>
                    </li>
                </ul>
            </div>
            
            <!-- POST SECTION -->
            <section class="post-section">
                <div class="container flex just-between">
                    <div class="article-column">
                        <article class="post-article about-reviews">
                            <h1 class="post-article-heading">
                                The Biotech Sector Is Hot, But These 3 Stocks Are Worth The Investment
                            </h1>
                            <!-- <div class="article-info">
                                <span class="article-theme-category">
                                    Cryptocurrency
                                </span>
                                <span class="article-publication-date">
                                    1 hour ago (Feb 02, 2023 04:19AM ET)
                                </span>
                            </div> -->
                            <div class="post-main-img-wrapper">
                                <img src="assets/img/news/The-Biotech-Sector-Is-Hot-But-These-3-Stocks-Are-Worth-The-Investment-001.jpg" alt="Image" class="post-main-img" loading="lazy">
                            </div>
                            <p class="regular-text">
                                The biotech sector has been one of the hottest areas of the stock market in recent years. According to a report by Grand View Research, the global biotechnology market size was valued at USD 729.5 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 15.5% from 2021 to 2028. With groundbreaking advancements in technology and science, the biotech industry is revolutionizing the way we think about healthcare. But with so many companies vying for investor attention, it can be difficult to identify the best biotech stocks to invest in. In this article, we will take a closer look at three biotech stocks that we believe are worth the investment.
                            </p>
                            <h3>
                                Moderna Inc. (MRNA)
                            </h3>
                            <div class="post-main-img-wrapper">
                                <img src="assets/img/news/The-Biotech-Sector-Is-Hot-But-These-3-Stocks-Are-Worth-The-Investment-002.jpg" alt="Image" class="post-main-img" loading="lazy">
                            </div>
                            <p class="regular-text">
                                Moderna Inc. has been one of the most talked-about biotech stocks in recent times, and for good reason. The company developed one of the leading COVID-19 vaccines in record time, which has helped the world to combat the pandemic. Moderna's stock price has experienced significant growth and volatility since the company went public in 2018. The company's initial public offering (IPO) was priced at $23 per share, and the stock began trading on the NASDAQ under the ticker symbol MRNA. Initially, the stock price remained relatively stable, but it began to increase significantly in early 2020 as the COVID-19 pandemic began to spread around the world.
                            </p>
                            <p class="regular-text">
                                Moderna's success in developing a COVID-19 vaccine that showed high efficacy rates in clinical trials led to a surge in investor interest and drove the company's stock price to new highs. In December 2020, Moderna's stock price reached an all-time high of over $180 per share, up from its IPO price of $23 per share. Since then, the stock price has fluctuated based on news related to the company's vaccine and its progress in developing other mRNA-based therapies.
                            </p>
                            <p class="regular-text">
                                Overall, Moderna's success in developing a COVID-19 vaccine has propelled the company into the spotlight and made it one of the most popular biotech stocks in the stock market. However, as with any stock, its popularity and stock price can be subject to volatility and fluctuations based on a variety of factors. The company's market cap is currently around USD 87.5 billion.
                            </p>
                            <p class="regular-text">
                                Here is a table outlining some of the key developments in Moderna's history:
                            </p>
                            <div class="table-wrapper">
                                <table class="information-table">
                                    <tr>
                                        <th>Year</th>
                                        <th>Development</th>
                                    </tr>
                                    <tr>
                                        <td>2010</td>
                                        <td>Moderna is founded</td>
                                    </tr>
                                    <tr>
                                        <td>2012</td>
                                        <td>Moderna enters into collaboration with AstraZeneca</td>
                                    </tr>
                                    <tr>
                                        <td>2013</td>
                                        <td>Moderna raises $110 million in Series B funding</td>
                                    </tr>
                                    <tr>
                                        <td>2015</td>
                                        <td>Moderna initiates clinical trials for its first mRNA vaccine</td>
                                    </tr>
                                    <tr>
                                        <td>2016</td>
                                        <td>Moderna enters into partnership with Merck</td>
                                    </tr>
                                    <tr>
                                        <td>2017</td>
                                        <td>Moderna raises $500 million in Series G funding</td>
                                    </tr>
                                    <tr>
                                        <td>2018</td>
                                        <td>Moderna goes public on the NASDAQ, raising $604 million</td>
                                    </tr>
                                    <tr>
                                        <td>2019</td>
                                        <td>Moderna begins clinical trials for its mRNA vaccine for cytomegalovirus</td>
                                    </tr>
                                    <tr>
                                        <td>2020</td>
                                        <td>Moderna develops a successful mRNA COVID-19 vaccine and begins mass production</td>
                                    </tr>
                                    <tr>
                                        <td>2021</td>
                                        <td>Moderna's COVID-19 vaccine is authorized for emergency use by regulatory agencies around the world</td>
                                    </tr>
                                    <tr>
                                        <td>2022</td>
                                        <td>Moderna announces plans to develop mRNA vaccines for seasonal flu and other infectious diseases</td>
                                    </tr>
                                </table>
                            </div>
                            <p class="regular-text">
                                This is not an exhaustive list, but it highlights some of the key milestones in Moderna's development over the years.
                            </p>
                            <h3>
                                Vertex Pharmaceuticals Inc. (VRTX)
                            </h3>
                            <div class="post-main-img-wrapper">
                                <img src="assets/img/news/The-Biotech-Sector-Is-Hot-But-These-3-Stocks-Are-Worth-The-Investment-003.jpg" alt="Image" class="post-main-img" loading="lazy">
                            </div>
                            <p class="regular-text">
                                Vertex Pharmaceuticals Inc. (VRTX) is a biotech company that specializes in treatments for cystic fibrosis, a rare genetic disease that affects the lungs and other organs. The company was founded in 1989 and is headquartered in Boston, Massachusetts.
                            </p>
                            <p class="regular-text">
                                Vertex has been a pioneer in the development of cystic fibrosis treatments and has multiple drugs in its portfolio that have been approved by the FDA. These drugs, which include Kalydeco, Orkambi, Symdeko, and Trikafta, target the underlying genetic mutations that cause cystic fibrosis and have been shown to improve lung function and reduce the frequency of respiratory infections in patients.
                            </p>
                            <p class="regular-text">
                                Vertex's success in the cystic fibrosis market has helped to position it as a leader in the biotech sector. The company's revenue for 2020 was USD 6.2 billion, driven by sales of its cystic fibrosis drugs. In addition to its work in cystic fibrosis, Vertex is also working on other therapies for other diseases such as sickle cell disease and alpha-1 antitrypsin deficiency.
                            </p>
                            <p class="regular-text">
                                Vertex's pipeline of drugs in development is focused on the use of small molecules to target specific disease-causing mutations, and the company has been successful in bringing these drugs to market. Vertex's strategy of focusing on a specific disease area and developing drugs that target specific genetic mutations has been a key driver of its success in the biotech industry.
                            </p>
                            <p class="regular-text">
                                As of March 2023, Vertex's market capitalization is around USD 58.4 billion, and the company is listed on the NASDAQ stock exchange under the ticker symbol VRTX. While Vertex's success in the cystic fibrosis market has helped to position it as a leader in the biotech sector, the company's future growth will depend on its ability to continue developing innovative therapies for other diseases and expanding its pipeline of drugs in development.
                            </p>
                            <div class="table-wrapper">
                                <table class="information-table">
                                    <tr>
                                        <th>Company Name</th>
                                        <th>Ticker Symbol</th>
                                        <th>Closing Price</th>
                                        <th>% Change</th>
                                        <th>52-Week High</th>
                                        <th>Volume (1.1 M)</th>
                                        <th>50-Day Avg. Volume (1.4 M)</th>
                                    </tr>
                                    <tr>
                                        <td><b>Vertex Pharmaceuticals Inc.</b></td>
                                        <td>VRTX</td>
                                        <td>$291.23</td>
                                        <td>+0.32%</td>
                                        <td>$325.19</td>
                                        <td>1.1 M</td>
                                        <td>1.4 M</td>
                                    </tr>
                                    <tr>
                                        <td><b>AbbVie Inc.</b></td>
                                        <td>ABBV</td>
                                        <td>$155.27</td>
                                        <td>+0.89%</td>
                                        <td>N/A</td>
                                        <td>N/A</td>
                                        <td>N/A</td>
                                    </tr>
                                    <tr>
                                        <td><b>Krystal Biotech Inc.</b></td>
                                        <td>KRYS</td>
                                        <td>$83.00</td>
                                        <td>+1.33%</td>
                                        <td>N/A</td>
                                        <td>N/A</td>
                                        <td>N/A</td>
                                    </tr>
                                    <tr>
                                        <td><b>Arcturus Therapeutics Holdings Inc.</b></td>
                                        <td>ARCT</td>
                                        <td>$16.30</td>
                                        <td>+0.31%</td>
                                        <td>N/A</td>
                                        <td>N/A</td>
                                        <td>N/A</td>
                                    </tr>
                                </table>
                            </div>
                            <p class="regular-text">
                                The table above summarizes the performance of Vertex Pharmaceuticals Inc. (VRTX) and its competitors on Wednesday, March, 2. VRTX closed at $291.23, which is $33.96 short of its 52-week high achieved on January 31st. The stock gained 0.32% during the trading session, which was the third consecutive day of gains. The trading volume of 1.1 million shares was below the 50-day average volume of 1.4 million shares.
                            </p>
                            <p class="regular-text">
                                When compared to its competitors, AbbVie Inc. (ABBV) rose 0.89% to $155.27, Krystal Biotech Inc. (KRYS) rose 1.33% to $83.00, and Arcturus Therapeutics Holdings Inc. (ARCT) rose 0.31% to $16.30. It's worth noting that there is no available data for the 52-week high of ABBV, KRYS, and ARCT.
                            </p>
                            <h3>
                                Gilead Sciences Inc. (GILD)
                            </h3>
                            <div class="post-main-img-wrapper">
                                <img src="assets/img/news/The-Biotech-Sector-Is-Hot-But-These-3-Stocks-Are-Worth-The-Investment-004.jpg" alt="Image" class="post-main-img" loading="lazy">
                            </div>
                            <p class="regular-text">
                                Gilead Sciences Inc. (GILD) is a leading biopharmaceutical company that focuses on developing and commercializing innovative medicines in the areas of liver diseases, HIV, oncology, inflammation, and respiratory diseases. The company was founded in 1987 and is headquartered in Foster City, California.
                            </p>
                            <p class="regular-text">
                                Gilead Sciences has a strong portfolio of drugs that have been approved by the FDA, including treatments for HIV, hepatitis B and C, and COVID-19. The company's HIV franchise includes several drugs that are used in combination therapy to treat HIV, such as Truvada, Atripla, and Biktarvy. Gilead has also been working on developing new drugs to treat viral diseases such as hepatitis B and C.
                            </p>
                            <p class="regular-text">
                                In addition to its infectious disease portfolio, Gilead has made significant strides in the areas of oncology and inflammation. The company's oncology drugs include Yescarta, a CAR-T therapy for the treatment of certain types of lymphoma, and Trodelvy, a drug used to treat metastatic triple-negative breast cancer. Gilead is also developing drugs for the treatment of fibrotic diseases such as idiopathic pulmonary fibrosis.
                            </p>
                            <p class="regular-text">
                                Gilead Sciences has a strong financial position, with a market capitalization of approximately $80.5 billion as of March 2023. The company reported revenue of $24.4 billion in 2021, with a net income of $4.4 billion. Gilead is committed to investing in research and development to continue developing innovative drugs and therapies to improve the lives of patients.
                            </p>
                            <p class="regular-text">
                                Like all biotech companies, investing in Gilead Sciences comes with risks. The company's success depends on its ability to continue developing new drugs and therapies that gain FDA approval and generate revenue. There is always a risk that a drug in development may fail clinical trials or not gain regulatory approval, which could impact the company's financial performance. Investors should conduct their own due diligence and consider the potential risks before investing in Gilead Sciences or any other biotech company.
                            </p>
                            <p class="regular-text">
                                On Wednesday, Gilead's stock price fell 1.17% to $79.59, marking the second consecutive day of losses. This decline was in contrast to the mixed performance of the overall stock market, with the Dow Jones Industrial Average rising slightly and the S&P 500 Index falling. Despite this recent dip in stock price, Gilead Sciences Inc. is still relatively close to its 52-week high of $89.74, which it achieved in December 2021.
                            </p>
                            <p class="regular-text">
                                When compared to some of its competitors, such as Johnson & Johnson, Pfizer, and Abbott Laboratories, Gilead's stock underperformed on Wednesday. However, it is important to note that trading volume for Gilead remained below its 50-day average volume of 6.8 million, with only 5.2 million shares traded on Wednesday. This indicates that the dip in stock price may have been influenced by lower trading activity rather than significant changes in market sentiment towards the company.
                            </p>
                            <p class="regular-text">
                                Overall, Gilead Sciences Inc. remains a major player in the biopharmaceutical industry, with a strong pipeline of drugs and a focus on developing therapies for serious illnesses. Despite the recent dip in stock price, the company's long-term prospects and continued efforts to innovate in the healthcare space suggest that it may still be a wise investment for those looking to add biotech stocks to their portfolio.
                            </p>
                            <div class="table-wrapper">
                                <table class="information-table">
                                    <tr>
                                        <th>Date</th>
                                        <th>Open</th>
                                        <th>High</th>
                                        <th>Low</th>
                                        <th>Close</th>
                                        <th>Adj Close</th>
                                        <th>Volume</th>
                                    </tr>
                                    <tr>
                                        <td>3/1/2021</td>
                                        <td>80.74</td>
                                        <td>81.29</td>
                                        <td>79.53</td>
                                        <td>79.59</td>
                                        <td>79.08</td>
                                        <td>6,803,200</td>
                                    </tr>
                                    <tr>
                                        <td>2/26/2021</td>
                                        <td>81.15</td>
                                        <td>81.50</td>
                                        <td>80.46</td>
                                        <td>80.53</td>
                                        <td>80.01</td>
                                        <td>4,919,300</td>
                                    </tr>
                                    <tr>
                                        <td>2/25/2021</td>
                                        <td>81.43</td>
                                        <td>82.22</td>
                                        <td>80.90</td>
                                        <td>81.05</td>
                                        <td>80.53</td>
                                        <td>4,174,800</td>
                                    </tr>
                                    <tr>
                                        <td>2/24/2021</td>
                                        <td>80.69</td>
                                        <td>82.04</td>
                                        <td>80.53</td>
                                        <td>81.66</td>
                                        <td>81.13</td>
                                        <td>4,523,700</td>
                                    </tr>
                                    <tr>
                                        <td>2/23/2021</td>
                                        <td>81.50</td>
                                        <td>82.27</td>
                                        <td>80.46</td>
                                        <td>80.65</td>
                                        <td>80.14</td>
                                        <td>7,435,700</td>
                                    </tr>
                                </table>
                            </div>
                            <p class="regular-text">
                                Shares of Gilead Sciences Inc. (GILD, -1.17%) shed 1.17% to $79.59 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average (DJIA, +0.02%) rising 0.02% to 32,661.84 and the S&P 500 Index (SPX, -0.47%) falling 0.47% to 3,951.39. This was the stock's second consecutive day of losses. Gilead Sciences Inc. closed $10.15 short of its 52-week high ($89.74), which the company achieved on December 13th.
                            </p>
                            <p class="regular-text">
                                The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ, -0.45%) fell 0.45% to $152.57, Pfizer Inc. (PFE, -0.96%) fell 0.96% to $40.18, and Abbott Laboratories (ABT, -0.87%) fell 0.87% to $100.83. Trading volume (5.2 million) remained 1.6 million below its 50-day average volume of 6.8 million.
                            </p>
                            <h2 class="section-heading">
                                Possible Risks Involved
                            </h2>
                            <p class="regular-text">
                                While the biotech sector offers high growth potential, it also comes with risks that investors should be aware of. Here are some potential risks associated with investing in the biotech sector:
                            </p>
                            <ol class="section-list">
                                <li>
                                    Clinical trial failures: Biotech companies invest heavily in clinical trials to test their drugs and therapies. These trials are costly and time-consuming, and there is always a risk that the results may not meet expectations, leading to significant financial losses for the company and its investors.
                                </li> 
                                <li>
                                    Regulatory challenges: Biotech companies are subject to extensive regulatory scrutiny and must obtain approval from regulatory agencies such as the FDA before their drugs can be marketed. The approval process can be lengthy and uncertain, and there is always a risk that a drug may not be approved or may face regulatory hurdles that delay its launch.
                                </li> 
                                <li> 
                                    Intellectual property risks: Biotech companies rely heavily on their intellectual property (IP) portfolios to protect their innovations and generate revenue. However, there is always a risk that their IP may be challenged or infringed upon by competitors, leading to legal battles that can be costly and time-consuming.
                                </li> 
                                <li>  
                                    Market competition: The biotech sector is highly competitive, with many companies vying for market share. While innovative products can help companies gain an edge, there is always a risk that competitors may develop similar products or therapies, leading to reduced market share and lower revenue.
                                </li> 
                                <li>  
                                    Financial risks: Biotech companies often operate with high levels of debt and rely on funding from investors to support their research and development efforts. Economic downturns or market volatility can lead to reduced funding and financial instability, which can impact a company's ability to operate and grow.
                                </li>
                            </ol>
                            <p class="regular-text">
                                Investors should carefully consider these risks before investing in biotech stocks and conduct thorough due diligence to assess a company's financial health, pipeline, and potential for growth. Diversification is also important to minimize risk and ensure a balanced portfolio.
                            </p>
                            <p class="regular-text">
                                In conclusion, the biotech sector is a hot area of the stock market, but not all biotech stocks are created equal. Moderna Inc., Vertex Pharmaceuticals Inc., and Gilead Sciences Inc. are three biotech stocks that we believe are worth the investment. These companies have a strong track record of success, innovative technology, and solid pipelines that position them for future growth. Investors who are interested in the biotech sector should consider these stocks for their portfolio. However, it's important to remember that investing in biotech stocks can be risky, and investors should conduct their own diligence before making any investment decisions.
                            </p>
                        </article>
                        <!-- <div class="also-like-news-wrapper">
                            <h2 class="section-heading">
                                You may also like
                            </h2>
                            <ul class="aslo-like-news-list flex">
                                <li class="aslo-like-news-list-item">
                                    <a href="news-post.html" class="also-like-post-link">
                                        <img src="assets/img/news/news-btc-md.png" alt="News Image" loading="lazy">
                                        <h4>How to clear bitcoins in the mixer so...</h4>
                                        <p class="also-like-date">Today, 10:21 / Cryptocurrency</p>
                                    </a>
                                </li>
                                <li class="aslo-like-news-list-item">
                                    <a href="news-post.html" class="also-like-post-link">
                                        <img src="assets/img/news/news-wall-street-md.png" alt="News Image" loading="lazy">
                                        <h4>How to clear bitcoins in the mixer so...</h4>
                                        <p class="also-like-date">Today, 10:21 / Cryptocurrency</p>
                                    </a>
                                </li>
                                <li class="aslo-like-news-list-item">
                                    <a href="news-post.html" class="also-like-post-link">
                                        <img src="assets/img/news/news-man-md.png" alt="News Image" loading="lazy">
                                        <h4>How to clear bitcoins in the mixer so...</h4>
                                        <p class="also-like-date">Today, 10:21 / Cryptocurrency</p>
                                    </a>
                                </li>
                                <li class="aslo-like-news-list-item">
                                    <a href="news-post.html" class="also-like-post-link">
                                        <img src="assets/img/news/news-people-in-the-office-md.png" alt="News Image" loading="lazy">
                                        <h4>How to clear bitcoins in the mixer so...</h4>
                                        <p class="also-like-date">Today, 10:21 / Cryptocurrency</p>
                                    </a>
                                </li>
                            </ul>
                        </div> -->
                        <!-- <div class="comments-wrapper">
                            <form action="comments.php" class="comments-form">
                                <h3 class="form-heading">
                                    Add a comment
                                </h3>
                                <div class="form-body">
                                    <textarea name="comment" id="commentInput" class="comments-textarea" placeholder="Write your thoughts here"></textarea>
                                    <div class="btn-wrapper flex just-end">
                                        <button class="btn action-btn">
                                            Post comment
                                        </button>
                                    </div>
                                </div>
                            </form>
                            <ul class="comments-list">
                                <li class="card customer-review-card flex">
                                    <div class="customer-reviewer-img-holder flex center just-center">
                                        <img src="assets/img/svg/grey-user-placeholder.svg" alt="Customer Image" class="customer-reviewer-img" loading="lazy">
                                    </div>
                                    <div class="customer-review-content">
                                        <div class="customer-review-content-heading flex center just-between">
                                            <div class="name-and-rating">
                                                <h3 class="customer-namer">
                                                    Maximilian
                                                </h3>
                                            </div>
                                            <div class="reviewing-date-holder section-text">
                                                Reviewed on 
                                                <span class="reviewing-date">June 24, 2023</span> 
                                            </div>
                                        </div>
                                        <div class="regular-text comment-text">
                                            Donec bibendum augue in erat porttitor, id pharetra purus mattis. Integer gravida ornare auctor. Sed mauris libero, pretium consectetur cursus eu, blandit at arcu. Morbi justo turpis, vulputate et elementum non, dapibus at ante. Morbi id augue id justo pulvinar elementum. Donec volutpat quam quis porta maximus. Donec bibendum augue in erat porttitor, id pharetra purus mattis. Integer gravida ornare auctor.
                                        </div>
                                    </div>
                                </li>
                                <li class="card customer-review-card flex">
                                    <div class="customer-reviewer-img-holder flex center just-center">
                                        <img src="assets/img/svg/grey-user-placeholder.svg" alt="Customer Image" class="customer-reviewer-img" loading="lazy">
                                    </div>
                                    <div class="customer-review-content">
                                        <div class="customer-review-content-heading flex center just-between">
                                            <div class="name-and-rating">
                                                <h3 class="customer-namer">
                                                    Maximilian
                                                </h3>
                                            </div>
                                            <div class="reviewing-date-holder section-text">
                                                Reviewed on 
                                                <span class="reviewing-date">June 24, 2023</span> 
                                            </div>
                                        </div>
                                        <div class="regular-text comment-text">
                                            Donec bibendum augue in erat porttitor, id pharetra purus mattis. Integer gravida ornare auctor. Sed mauris libero, pretium consectetur cursus eu, blandit at arcu. Morbi justo turpis, vulputate et elementum non, dapibus at ante. Morbi id augue id justo pulvinar elementum. Donec volutpat quam quis porta maximus. Donec bibendum augue in erat porttitor, id pharetra purus mattis. Integer gravida ornare auctor.
                                        </div>
                                    </div>
                                </li>
                                <li class="card customer-review-card flex">
                                    <div class="customer-reviewer-img-holder flex center just-center">
                                        <img src="assets/img/svg/grey-user-placeholder.svg" alt="Customer Image" class="customer-reviewer-img" loading="lazy">
                                    </div>
                                    <div class="customer-review-content">
                                        <div class="customer-review-content-heading flex center just-between">
                                            <div class="name-and-rating">
                                                <h3 class="customer-namer">
                                                    Maximilian
                                                </h3>
                                            </div>
                                            <div class="reviewing-date-holder section-text">
                                                Reviewed on 
                                                <span class="reviewing-date">June 24, 2023</span> 
                                            </div>
                                        </div>
                                        <div class="regular-text comment-text">
                                            Donec bibendum augue in erat porttitor, id pharetra purus mattis. Integer gravida ornare auctor. Sed mauris libero, pretium consectetur cursus eu, blandit at arcu. Morbi justo turpis, vulputate et elementum non, dapibus at ante. Morbi id augue id justo pulvinar elementum. Donec volutpat quam quis porta maximus. Donec bibendum augue in erat porttitor, id pharetra purus mattis. Integer gravida ornare auctor.
                                        </div>
                                    </div>
                                </li>
                            </ul>
                        </div> -->
                    </div>
                    <div class="sidebar-column">
                        <div class="sidebar-sticky-wrapper">
                            <div class="card best-broker-card">
                                <div class="card-header flex center">
                                    Best stock brokers
                                </div>
                                <div class="card-content">
                                    <ul class="card-list">
                                        <li class="card-list-item">
                                            <a href="brokers/exness.html" class="broker-link flex center just-between">
                                                <div class="flex center">
                                                    <div class="circle-number flex center just-center">1</div>
                                                    <img src="assets/img/brokers/exness.svg" width="48" height="48" alt="Exness" class="broker-logo" loading="lazy">
                                                    <h4 class="broker-name">Exness</h4>
                                                </div>
                                                <img src="assets/img/svg/grey-arrow-right-ext.svg" width="16" height="15" alt="Arrow right" class="arrow-right-icon" loading="lazy">
                                            </a>
                                        </li>
                                        <li class="card-list-item">
                                            <a href="brokers/capitalcom.html" class="broker-link flex center just-between">
                                                <div class="flex center">
                                                    <div class="circle-number flex center just-center">2</div>
                                                    <img src="assets/img/brokers/capital.svg" width="48" height="48" alt="Capital" class="broker-logo" loading="lazy">
                                                    <h4 class="broker-name">Capital</h4>
                                                </div>
                                                <img src="assets/img/svg/grey-arrow-right-ext.svg" width="16" height="15" alt="Arrow right" class="arrow-right-icon" loading="lazy">
                                            </a>
                                        </li>
                                        <li class="card-list-item">
                                            <a href="brokers/fxpro.html" class="broker-link flex center just-between">
                                                <div class="flex center">
                                                    <div class="circle-number flex center just-center">3</div>
                                                    <img src="assets/img/brokers/fxpro.svg" width="48" height="48" alt="FxPro" class="broker-logo" loading="lazy">
                                                    <h4 class="broker-name">FxPro</h4>
                                                </div>
                                                <img src="assets/img/svg/grey-arrow-right-ext.svg" width="16" height="15" alt="Arrow right" class="arrow-right-icon" loading="lazy">
                                            </a>
                                        </li>
                                        <li class="card-list-item">
                                            <a href="brokers/naga.html" class="broker-link flex center just-between">
                                                <div class="flex center">
                                                    <div class="circle-number flex center just-center">4</div>
                                                    <img src="assets/img/brokers/naga.svg" width="48" height="48" alt="Naga" class="broker-logo" loading="lazy">
                                                    <h4 class="broker-name">Naga</h4>
                                                </div>
                                                <img src="assets/img/svg/grey-arrow-right-ext.svg" width="16" height="15" alt="Arrow right" class="arrow-right-icon" loading="lazy">
                                            </a>
                                        </li>
                                        <li class="card-list-item">
                                            <a href="brokers/primexbt.html" class="broker-link flex center just-between">
                                                <div class="flex center">
                                                    <div class="circle-number flex center just-center">5</div>
                                                    <img src="assets/img/brokers/primexbt.svg" width="48" height="48" alt="PrimeXBT" class="broker-logo" loading="lazy">
                                                    <h4 class="broker-name">PrimeXBT</h4>
                                                </div>
                                                <img src="assets/img/svg/grey-arrow-right-ext.svg" width="16" height="15" alt="Arrow right" class="arrow-right-icon" loading="lazy">
                                            </a>
                                        </li>
                                    </ul>
                                </div>
                            </div>
                            <div class="card top-news-card">
                                <div class="card-header">
                                    <h4 class="news-card-heading">
                                        Top news
                                    </h4>
                                </div>
                                <div class="card-content">
                                    <ul class="news-list">
                                        <li class="news-list-item">
                                            <a href="news/The-Biotech-Sector-Is-Hot-But-These-3-Stocks-Are-Worth-The-Investment.html" class="news-list-item-link flex center">
                                                <img src="assets/img/news/The-Biotech-Sector-Is-Hot-But-These-3-Stocks-Are-Worth-The-Investment-001.jpg" width="68" height="68" alt="News" class="news-list-item-img" loading="lazy">
                                                <div class="news-list-item-content">
                                                    <h4 class="news-list-item-title">
                                                        The Biotech Sector Is Hot, But These 3 Stocks Are Worth The Investment
                                                    </h4>
                                                    <p class="news-list-item-date">
                                                        Today, 08:21
                                                    </p>
                                                </div>
                                            </a>
                                        </li>
                                        <li class="news-list-item">
                                            <a href="news/The-Best-Forex-Trading-Strategies-That-Work.html" class="news-list-item-link flex center">
                                                <img src="assets/img/news/The-Best-Forex-Trading-Strategies-That-Work-001.jpg" width="68" height="68" alt="News" class="news-list-item-img" loading="lazy">
                                                <div class="news-list-item-content">
                                                    <h4 class="news-list-item-title">
                                                        The Best Forex Trading Strategies That Work
                                                    </h4>
                                                    <p class="news-list-item-date">
                                                        Yesterday, 16:05
                                                    </p>
                                                </div>
                                            </a>
                                        </li>
                                        <li class="news-list-item">
                                            <a href="news/3-Blue-Chip-Stocks-To-Buy-For-A-Diversified-Portfolio.html" class="news-list-item-link flex center">
                                                <img src="assets/img/news/3-Blue-Chip-Stocks-To-Buy-For-A-Diversified-Portfolio-001.jpg" width="68" height="68" alt="News" class="news-list-item-img" loading="lazy">
                                                <div class="news-list-item-content">
                                                    <h4 class="news-list-item-title">
                                                        3 Blue-Chip Stocks To Buy For A Diversified Portfolio
                                                    </h4>
                                                    <p class="news-list-item-date">
                                                        Yesterday, 11:16
                                                    </p>
                                                </div>
                                            </a>
                                        </li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </section>

            <!-- SUBSCRIBE -->
            <section class="subscribe-section">
                <div class="container flex center just-between">
                    <h3 class="section-heading subscribe-heading">
                        Subscribe to our email newsletter
                    </h3>
                    <form class="subscribe-form">
                        <input type="text" placeholder="Enter your email" class="subscribe-form-input">
                        <button class="action-btn">
                            Subscribe
                        </button>
                    </form>
                </div>
            </section>
        </main>

        <!-- FOOTER -->
        <footer class="footer">
            <div class="container flex just-between">
                <div class="logo-part">
                    <a href="index.html" class="footer-logo-link">
                        <img src="assets/img/svg/logo.svg" alt="Logo" class="footer-logo" loading="lazy">
                    </a>
                    <p class="footer-copyright">
                        © <span class="year">2023</span> BrokersNear Group LLC. <br>
                        All rights reserved.
                    </p>
                </div>
                <div class="footer-links-part flex">
                    <div class="footer-links-group">
                        <h4>Main menu</h4>
                        <ul>
                            <li><a href="reviews.html">Broker Reviews</a></li>
                            <li><a href="best-brokers.html">Best Brokers</a></li>
                            <li><a href="about.html">About</a></li>
                            <li><a href="contact.html">Contacts</a></li>
                        </ul>
                    </div>
                    <div class="footer-links-group">
                        <h4>Top Brokers</h4>
                        <ul>
                            <li><a href="brokers/exness.html">Exness</a></li>
                            <li><a href="brokers/capitalcom.html">Capital.com</a></li>
                            <li><a href="brokers/fxpro.html">FxPro</a></li>
                            <li><a href="brokers/naga.html">Naga</a></li>
                            <li><a href="brokers/primexbt.html">PrimeXBT</a></li>
                        </ul>
                    </div>
                    <div class="footer-links-group">
                        <h4>Best brokers for</h4>
                        <ul>
                                <li><a href="best-brokers.html">Best brokers</a></li>
                                <li><a href="best-crypto-brokers.html">Best crypto brokers</a></li>
                                <li><a href="best-brokers-for-beginners.html">Best brokers for beginners</a></li>
                                <li><a href="best-stock-brokers.html">Best stock brokers</a></li>
                                <li><a href="best-forex-brokers.html">Best forex brokers</a></li>
                                <li><a href="best-trading-platform.html">Best trading platform</a></li>
                            </ul>
                    </div>
                    <div class="footer-links-group">
                        <h4>Information</h4>
                        <ul>
                            <li><a href="tech/privacy.html">Privacy Policy</a></li>
                            <li><a href="tech/terms.html">Terms and conditions</a></li>
                            <li><a href="team.html">Our Team</a></li>
                            <li><a href="news.html">News</a></li>
                        </ul>
                    </div>
                    <div class="footer-links-group">
                        <h4>Additional</h4>
                        <ul>
                            <li><a href="tech/sitemap.html">Sitemap</a></li>
                            <li><a href="faq.html">FAQ</a></li>
                            <li><a href="careers.html">Careers</a></li>
                        </ul>
                    </div>
                </div>
            </div>
        </footer>
    </div>
    
    <!-- COOKIES NOTICE -->
    <div class="cookies-notice flex">
        <div class="cookies-motice-text-part">
            <h3 class="flex center">
                Cookies notice
            </h3>
            <p class="section-text">
                We and selected third parties use cookies or similar technologies for technical purposes and, with your consent, for “basic interactions & functionalities”. Denying consent may make related features unavailable.
            </p>
        </div>
        <div class="btns-wrapper flex column">
            <button class="btn action-btn" onclick="cookiesNoticeHide()">
                Accept
            </button>
            <button class="btn" onclick="cookiesNoticeHide()">
                Reject
            </button>
        </div>
    </div>

    <!-- MOBILE MENU -->
    <div class="mobile-menu flex column" id="mobileMenu">
        <div class="mobile-menu-header header">
            <div class="container flex center">
                <a href="index.html" class="header-logo-link">
                    <img src="assets/img/svg/logo.svg" alt="Logo" class="header-logo" loading="lazy">
                </a>
                <div class="header-menu-btn-wrapper">
                    <img src="assets/img/svg/white-close-icon.svg" width="24" height="16" alt="Menu" class="header-menu-btn-close" loading="lazy" aria-label="Close Menu">
                </div>
            </div>
        </div>
        <div class="container mobile-menu-main">
            <div class="header-search-bar">
                <input type="text" placeholder="Enter broker title" class="header-search-input">
            </div>
            <nav class="navigation">
                <ul class="nav-list flex column center">
                    <li class="nav-list-item">
                        <a href="reviews.html" class="nav-list-item-link">
                            Brokers Reviews
                        </a>
                    </li>
                    <li class="nav-list-item mob dropdown">
                            Best brokers
                        </li>
                        <ul class="mob-dropdown-menu">
                            <li class="mob-dropdown-menu-item">
                                <a href="best-crypto-brokers.html" class="mob-dropdown-menu-item-link">
                                    Best crypto brokers
                                </a>
                            </li>
                            <li class="mob-dropdown-menu-item">
                                <a href="best-forex-brokers.html" class="mob-dropdown-menu-item-link">
                                    Best Forex brokers
                                </a>
                            </li>
                            <li class="mob-dropdown-menu-item">
                                <a href="best-stock-brokers.html" class="mob-dropdown-menu-item-link">
                                    Best stock brokers
                                </a>
                            </li>
                            <li class="mob-dropdown-menu-item">
                                <a href="best-brokers-for-beginners.html" class="mob-dropdown-menu-item-link">
                                    Best brokers for beginners
                                </a>
                            </li>
                            <li class="mob-dropdown-menu-item">
                                <a href="best-trading-platform.html" class="mob-dropdown-menu-item-link">
                                    Best trading platform
                                </a>
                            </li>
                        </ul>
                    <li class="nav-list-item">
                        <a href="about.html" class="nav-list-item-link">
                            About
                        </a>
                    </li>
                    <li class="nav-list-item">
                        <a href="contact.html" class="nav-list-item-link">
                            Contacts
                        </a>
                    </li>
                </ul>
            </nav>
        </div>
        <div class="mobile-menu-footer flex center just-center">
            <!-- <a href="javascript:void(0)" class="btn btn-green-outline log-in">
                Log in
            </a>
            <a href="javascript:void(0)" class="btn action-btn sign-up">
                Sign up
            </a> -->
        </div>
    </div>

    <script src="assets/js/main.js"></script>
</body>
</html>